High-CBD cannabis extract for complex regional pain syndrome treatment
Treatments studied
Part of Brain & nervous system, Mental health, Pain clinical trials.
This study tests a high-CBD cannabis extract (BRC-002) to see if it can help reduce pain and improve health in people with Complex Regional Pain Syndrome (CRPS). Participants will not use opioids or other cannabis during the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 75 years old.
- You have been diagnosed with Complex Regional Pain Syndrome (CRPS) for at least 3 months.
- You have not used any cannabis, hemp, or CBD products in the past 30 days and agree not to use them during the study.
- You agree not to use opioids or barbiturates during the study.
- You do not have serious health conditions like heart disease, diabetes, kidney/liver disease, a weakened immune system, or certain neurological or psychiatric disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a low dose of naltrexone, a medication that may help calm overactive immune and pain signals, can reduce pain and improve daily life in people with complex regional pain syndrome (CRPS), a chronic condition that often causes severe pain and swelling.
This study is testing a new way to measure CRPS symptoms and other chronic pain in one arm or leg. It aims to help doctors better understand and treat your condition.
This trial tests whether low-dose naltrexone can reduce symptoms of complex regional pain syndrome (CRPS), a long-lasting pain condition in an arm or leg. It may help by targeting pain signaling, but you must meet specific CRPS diagnosis and medication rules to join.
This Phase 2 study tests cannabis-derived products to see if they reduce neuropathic (nerve-related) pain in veterans. It may help people whose pain is persistent and causes significant daily impact, especially if certain exam tests show allodynia (pain from normally non-painful touch).
This trial tests a new type of spinal cord stimulator that automatically adjusts to your pain signals. It may help people with complex regional pain syndrome (CRPS) who have not tried this kind of therapy before.
This early study looks at how the brain may respond to cannabis to reduce long-lasting lower back pain. You may be asked to follow strict rules about cannabis, opioids, and safety checks (including MRI) to help researchers understand the brain mechanisms.
Hear when a new Complex Regional Pain Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.